-
Something wrong with this record ?
Keratin 36, a specific marker of tongue filiform papillae, is downregulated in squamous cell carcinoma of the mobile tongue
V. Brychtova, PJ. Coates, V. Hrabal, L. Boldrup, P. Fabian, B. Vojtesek, N. Sgaramella, K. Nylander,
Language English Country Great Britain
Document type Journal Article
NLK
PubMed Central
from 2013
ProQuest Central
from 2013-01-01
Health & Medicine (ProQuest)
from 2013-01-01
PubMed
32257198
DOI
10.3892/mco.2020.2005
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
Human keratin 36 (K36) is a member of the hair keratin family and is a marker of hair cortex differentiation. The human KRT36 gene is located on the long arm of chromosome 17 and belongs to the cluster of structurally unrelated acidic hair keratins. Recently, it has been reported that KRT36 mRNA is specifically expressed in normal tongue epithelium and downregulated in squamous cell carcinomas of the mobile tongue. Furthermore, KRT36 levels have been reported to be downregulated in clinically normal mobile tongue tissue that is adjacent to tumours, suggesting it could be a marker of pre-neoplastic changes. However, the exact role and the potential role of K36 in tongue tumour formation remains unclear. The aim of the present study was to investigate expression of K36 in a series of squamous cell carcinomas of the mobile tongue, normal mobile tongue and a small panel of other human tissues (normal tissue from the appendix, cervix, hair, lip, mamilla, nail, oesophagus, skin, thymus and vagina) and selected cancer tissue (cervical cancer, melanoma and basal cell carcinoma). Affinity purified polyclonal antibodies against K36 were generated and used for immunohistochemical analysis. The results revealed that in the normal tongue, K36 was detected specifically in the filiform papillae of the dorsal surface of the tongue. Additionally, none of the tongue cancer tissue samples were K36-positive. Immunostaining also revealed that K36 was expressed in nail beds, Hassal's corpuscles in the thymus and the hair cortex. However, K36 was not expressed in the squamous epithelia of the skin, cervix and oesophagus, and the squamous cells of cervical carcinomas, basal cell carcinoma or melanoma. The present data indicated that K36 may be inactivated in tumours of the tongue. However, whether this is part of the tumoural process or if it is an effect of the tumour itself remains to be elucidated.
Department of Medical Biosciences Umea University SE 901 85 Umea Sweden
Department of Pathology Masaryk Memorial Cancer Institute CZ 656 53 Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20019250
- 003
- CZ-PrNML
- 005
- 20210208135153.0
- 007
- ta
- 008
- 201103s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3892/mco.2020.2005 $2 doi
- 035 __
- $a (PubMed)32257198
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Brychtova, Veronika $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, CZ-656 53 Brno, Czech Republic.
- 245 10
- $a Keratin 36, a specific marker of tongue filiform papillae, is downregulated in squamous cell carcinoma of the mobile tongue / $c V. Brychtova, PJ. Coates, V. Hrabal, L. Boldrup, P. Fabian, B. Vojtesek, N. Sgaramella, K. Nylander,
- 520 9_
- $a Human keratin 36 (K36) is a member of the hair keratin family and is a marker of hair cortex differentiation. The human KRT36 gene is located on the long arm of chromosome 17 and belongs to the cluster of structurally unrelated acidic hair keratins. Recently, it has been reported that KRT36 mRNA is specifically expressed in normal tongue epithelium and downregulated in squamous cell carcinomas of the mobile tongue. Furthermore, KRT36 levels have been reported to be downregulated in clinically normal mobile tongue tissue that is adjacent to tumours, suggesting it could be a marker of pre-neoplastic changes. However, the exact role and the potential role of K36 in tongue tumour formation remains unclear. The aim of the present study was to investigate expression of K36 in a series of squamous cell carcinomas of the mobile tongue, normal mobile tongue and a small panel of other human tissues (normal tissue from the appendix, cervix, hair, lip, mamilla, nail, oesophagus, skin, thymus and vagina) and selected cancer tissue (cervical cancer, melanoma and basal cell carcinoma). Affinity purified polyclonal antibodies against K36 were generated and used for immunohistochemical analysis. The results revealed that in the normal tongue, K36 was detected specifically in the filiform papillae of the dorsal surface of the tongue. Additionally, none of the tongue cancer tissue samples were K36-positive. Immunostaining also revealed that K36 was expressed in nail beds, Hassal's corpuscles in the thymus and the hair cortex. However, K36 was not expressed in the squamous epithelia of the skin, cervix and oesophagus, and the squamous cells of cervical carcinomas, basal cell carcinoma or melanoma. The present data indicated that K36 may be inactivated in tumours of the tongue. However, whether this is part of the tumoural process or if it is an effect of the tumour itself remains to be elucidated.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Coates, Philip J $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, CZ-656 53 Brno, Czech Republic.
- 700 1_
- $a Hrabal, Vaclav $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, CZ-656 53 Brno, Czech Republic.
- 700 1_
- $a Boldrup, Linda $u Department of Medical Biosciences, Umea University, SE-901 85 Umea, Sweden.
- 700 1_
- $a Fabian, Pavel $u Department of Pathology, Masaryk Memorial Cancer Institute, CZ-656 53 Brno, Czech Republic.
- 700 1_
- $a Vojtesek, Borivoj $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, CZ-656 53 Brno, Czech Republic.
- 700 1_
- $a Sgaramella, Nicola $u Department of Medical Biosciences, Umea University, SE-901 85 Umea, Sweden.
- 700 1_
- $a Nylander, Karin $u Department of Medical Biosciences, Umea University, SE-901 85 Umea, Sweden.
- 773 0_
- $w MED00205361 $t Molecular and clinical oncology $x 2049-9450 $g Roč. 12, č. 5 (2020), s. 421-428
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32257198 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201103 $b ABA008
- 991 __
- $a 20210208135152 $b ABA008
- 999 __
- $a ind $b bmc $g 1586028 $s 1109448
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 12 $c 5 $d 421-428 $e 20200226 $i 2049-9450 $m Molecular and clinical oncology $n Mol Clin Oncol $x MED00205361
- LZP __
- $a Pubmed-20201103